DZ3477A1 - - Google Patents

Info

Publication number
DZ3477A1
DZ3477A1 DZ013477A DZ013477A DZ3477A1 DZ 3477 A1 DZ3477 A1 DZ 3477A1 DZ 013477 A DZ013477 A DZ 013477A DZ 013477 A DZ013477 A DZ 013477A DZ 3477 A1 DZ3477 A1 DZ 3477A1
Authority
DZ
Algeria
Application number
DZ013477A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ3477(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Application granted granted Critical
Publication of DZ3477A1 publication Critical patent/DZ3477A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ013477A 2000-10-12 2001-09-28 DZ3477A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12
PCT/EP2001/011227 WO2002030389A1 (fr) 2000-10-12 2001-09-28 Nouvelle poudre a inhaler a teneur en tiotropium

Publications (1)

Publication Number Publication Date
DZ3477A1 true DZ3477A1 (fr) 2002-04-18

Family

ID=7659578

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013477A DZ3477A1 (fr) 2000-10-12 2001-09-28

Country Status (49)

Country Link
US (4) US7070800B2 (fr)
EP (2) EP1292281B1 (fr)
JP (1) JP3870159B2 (fr)
KR (1) KR100488644B1 (fr)
CN (1) CN1210017C (fr)
AP (1) AP1712A (fr)
AR (1) AR031819A1 (fr)
AT (1) ATE275391T1 (fr)
AU (1) AU757008B2 (fr)
BG (1) BG65753B1 (fr)
BR (1) BR0107304A (fr)
CA (1) CA2395653C (fr)
CR (1) CR6937A (fr)
CU (1) CU23284B7 (fr)
CZ (1) CZ301465B6 (fr)
DE (1) DE50103551C5 (fr)
DK (1) DK1292281T3 (fr)
DZ (1) DZ3477A1 (fr)
EA (1) EA004034B1 (fr)
EC (2) ECSP024268A (fr)
EE (1) EE04414B1 (fr)
EG (1) EG24139A (fr)
ES (1) ES2227268T3 (fr)
GE (1) GEP20063865B (fr)
HK (1) HK1051812A1 (fr)
HR (1) HRP20020437B1 (fr)
HU (1) HU226982B1 (fr)
IL (2) IL149984A0 (fr)
IS (1) IS2360B (fr)
MA (1) MA25843A1 (fr)
ME (2) MEP40108A (fr)
MX (1) MXPA02005666A (fr)
MY (1) MY123544A (fr)
NO (1) NO331956B1 (fr)
NZ (1) NZ519406A (fr)
OA (1) OA12522A (fr)
PE (1) PE20020577A1 (fr)
PL (1) PL200063B1 (fr)
PT (1) PT1292281E (fr)
RS (1) RS50197B (fr)
SA (1) SA01220460B1 (fr)
SI (1) SI1292281T1 (fr)
SK (1) SK285389B6 (fr)
TR (1) TR200402367T4 (fr)
TW (1) TWI285553B (fr)
UA (1) UA72014C2 (fr)
UY (1) UY26959A1 (fr)
WO (1) WO2002030389A1 (fr)
ZA (1) ZA200204378B (fr)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0107304A (pt) 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
EP2283818B1 (fr) 2000-11-30 2017-08-02 Vectura Limited Procede de preparation de particules destinees a etre utilisees dans une composition pharmaceutique
WO2002043700A2 (fr) 2000-11-30 2002-06-06 Vectura Limited Particules servant dans une composition pharmaceutique
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
DE10128779A1 (de) * 2001-06-13 2003-01-02 Boehringer Ingelheim Pharma Verfahren zur Reinigung von Hartgelatinekapseln
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
AU2003221531B2 (en) * 2002-04-04 2008-10-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
AU2003276837B2 (en) * 2002-06-12 2006-07-20 Epigenesis Pharmaceuticals, Llc. Combination of anti-muscarinic agents and non-glucocorticoid steroids
JP2006516531A (ja) * 2002-08-21 2006-07-06 ノートン　ヘルスケアー　リミテッド 吸入組成物
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
US8273331B2 (en) * 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20050058606A1 (en) * 2002-12-16 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing HFC solution formulations
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
JP2007517537A (ja) * 2003-06-13 2007-07-05 アドバンスト インハレーション リサーチ，インコーポレイテッド 吸入用低投薬量医薬粉末
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
CN101407514B (zh) * 2003-11-03 2013-05-29 贝林格尔.英格海姆国际有限公司 噻托铵盐、包含噻托铵盐的药物制剂及其用途
EP2083007B1 (fr) 2003-11-03 2013-04-24 Boehringer Ingelheim International Gmbh Sels de tiotropium, leur procédé de fabrication et formules de médicament les contenant
CA2547782A1 (fr) * 2003-12-03 2005-06-16 Microdrug Ag Produit medical contenant du tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
PL1691783T3 (pl) * 2003-12-03 2010-05-31 Boehringer Ingelheim Int Inhalator suchego proszku ze wstępnym odmierzaniem do leków wrażliwych na wilgoć
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
ES2613391T3 (es) 2005-02-10 2017-05-24 Glaxo Group Limited Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma
DK1881980T3 (da) 2005-05-02 2012-10-01 Boehringer Ingelheim Int Nye krystalline former af tiotropiumbromid
BRPI0611763A2 (pt) * 2005-06-15 2010-09-28 Boehringer Ingelheim Int processo para a preparação de sais de tiotrópio, sais de tiotrópio como tais e composições farmacêuticas dos mesmos
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CN102731494A (zh) 2005-12-19 2012-10-17 西科尔公司 噻托溴铵的新形式及其制备方法
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
WO2007075838A2 (fr) * 2005-12-19 2007-07-05 Sicor Inc. Bromure de tiotropium pur et stable
US20080051582A1 (en) * 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
WO2009016133A1 (fr) * 2007-07-27 2009-02-05 Cargill, Incorporated Micronisation de polyols
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
WO2009137819A1 (fr) 2008-05-09 2009-11-12 Innovative Pulmonary Solutions, Inc. Systèmes, ensembles et procédés utilisables pour le traitement d'un arbre bronchique
EP2172190A1 (fr) 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Particules inhalables comprenant du tiotropium
EP2409977A4 (fr) 2009-03-17 2012-09-26 Daiichi Sankyo Co Ltd Dérivé d'amide
KR101722290B1 (ko) 2009-10-27 2017-03-31 호라이라 인코포레이티드 냉각 가능한 에너지 에미팅 어셈블리를 갖는 전달 장치
EP4111995A1 (fr) 2009-11-11 2023-01-04 Nuvaira, Inc. Appareil pour traiter un tissu et contrôler une sténose
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
US9259376B2 (en) 2010-06-03 2016-02-16 Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. Process for dry powder formulations
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US20150165038A1 (en) * 2012-02-10 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Compositions comprising muscarinic receptor antagonist and sorbitol
WO2013127738A1 (fr) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Nouvelle formulation de tiotropium contenant un gaz propulseur
RU2522213C2 (ru) * 2012-06-07 2014-07-10 Шолекс Девелопмент Гмбх, Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащих в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
WO2014007772A2 (fr) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions d'inhalation contenant du glucose anhydre
WO2014007769A1 (fr) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprenant un antagoniste du récepteur muscarinique et du glucose anhydre
US20150224197A1 (en) * 2012-07-05 2015-08-13 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation compositions
US20150165037A1 (en) * 2012-07-05 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising corticosteroid and sorbitol
WO2014007771A2 (fr) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions d'inhalation comprenant un antagoniste du récepteur muscarinique
GEP201706672B (en) 2012-07-05 2017-05-25 Arven Ilac Sanayi Ve Ticaret As Dry powder inhaler compositions comprising long acting muscorinic antagonists
EP2705838A1 (fr) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Préparations de tiotropium
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
WO2015065222A1 (fr) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Préparation pharmaceutique inhalable pour le traitement de l'asthme bronchial et de maladies à obstruction chronique des poumons contenant du bromure de tiotropium micronisé en qualité de substance active, et procédé de production
EP2913332A1 (fr) 2014-02-27 2015-09-02 Euticals S.P.A. Forme cristalline de bromure de tiotropium et de lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
EP3159277B1 (fr) 2015-10-23 2019-05-29 Arven Ilac Sanayi Ve Ticaret A.S. Blister pour formulation inhalable de bromure de tiotropium
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
PL3393451T3 (pl) 2015-12-24 2023-12-27 Philip Morris Products S.A. Aromatyzowany proszek nikotynowy
EA201992234A1 (ru) 2017-03-23 2020-02-05 Сингапур Хелт Сервисиз Пте Лтд Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента
EP4108230A1 (fr) 2021-06-24 2022-12-28 Laboratoires SMB Nouvelle composition de poudre sèche de tiotropium pour inhalation
GR1010358B (el) * 2021-09-14 2022-12-16 Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3860618A (en) 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
DE2540633A1 (de) 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
JPS60172442A (ja) 1984-02-20 1985-09-05 Fanuc Ltd ならい加工およびνｃ加工による機械加工装置
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
ATE170745T1 (de) 1991-04-08 1998-09-15 Nippon Shinyaku Co Ltd Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
GB9311892D0 (en) 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
EP1033128B2 (fr) 1993-09-28 2011-11-23 R.P. Scherer GmbH Procédé de production de capsules en gélatine molle
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
DE19515625C2 (de) 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
US6235725B1 (en) * 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
CZ303154B6 (cs) * 1998-11-13 2012-05-09 Jagotec Ag Suchá prášková formulace k inhalaci obsahující stearát horecnatý
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
US20040002548A1 (en) 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
JP3931486B2 (ja) 1999-06-24 2007-06-13 住友化学株式会社 ポジ型レジスト組成物
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
BR0107304A (pt) 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10126924A1 (de) 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US6482429B1 (en) 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
AU2003221531B2 (en) 2002-04-04 2008-10-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation

Also Published As

Publication number Publication date
MEP40108A (en) 2011-02-10
BG106730A (bg) 2003-03-31
UA72014C2 (en) 2005-01-17
YU36302A (sh) 2002-09-19
CA2395653C (fr) 2006-05-09
HUP0203885A2 (hu) 2003-03-28
AP1712A (en) 2007-01-24
DK1292281T3 (da) 2004-10-11
CU23284B7 (es) 2008-06-30
HK1051812A1 (en) 2003-08-22
ECSP024268A (es) 2002-08-01
US7070800B2 (en) 2006-07-04
PL356840A1 (en) 2004-07-12
WO2002030389A1 (fr) 2002-04-18
PE20020577A1 (es) 2002-08-08
MXPA02005666A (es) 2002-11-29
DE50103551C5 (de) 2014-08-21
EG24139A (en) 2008-08-06
NO331956B1 (no) 2012-05-14
KR100488644B1 (ko) 2005-05-11
US20040228806A1 (en) 2004-11-18
SK7062002A3 (en) 2002-10-08
GEP20063865B (en) 2006-07-10
PL200063B1 (pl) 2008-12-31
SK285389B6 (sk) 2006-12-07
OA12522A (en) 2006-05-30
BG65753B1 (bg) 2009-10-30
EP1430887A1 (fr) 2004-06-23
ATE275391T1 (de) 2004-09-15
IL149984A (en) 2007-06-03
EP1292281A1 (fr) 2003-03-19
JP2004510805A (ja) 2004-04-08
SA01220460B1 (ar) 2006-10-31
US20020110529A1 (en) 2002-08-15
HRP20020437B1 (en) 2005-10-31
EA004034B1 (ru) 2003-12-25
NO20022414L (no) 2002-05-30
DE50103551D1 (de) 2004-10-14
CZ301465B6 (cs) 2010-03-10
TWI285553B (en) 2007-08-21
US20080292563A1 (en) 2008-11-27
JP3870159B2 (ja) 2007-01-17
EA200200551A1 (ru) 2002-12-26
ECSP034546A (es) 2003-06-25
MA25843A1 (fr) 2003-07-01
IS2360B (is) 2008-05-15
PT1292281E (pt) 2004-11-30
MY123544A (en) 2006-05-31
EE04414B1 (et) 2005-02-15
NO20022414D0 (no) 2002-05-22
CN1392795A (zh) 2003-01-22
CA2395653A1 (fr) 2002-04-18
ZA200204378B (en) 2003-05-19
NZ519406A (en) 2003-07-25
IL149984A0 (en) 2002-12-01
HRP20020437A2 (en) 2004-08-31
BR0107304A (pt) 2002-08-13
TR200402367T4 (tr) 2004-12-21
AP2003002774A0 (en) 2003-03-31
KR20020063912A (ko) 2002-08-05
SI1292281T1 (en) 2004-12-31
EE200200428A (et) 2003-02-17
US20060039868A1 (en) 2006-02-23
UY26959A1 (es) 2002-06-20
HUP0203885A3 (en) 2005-01-28
CZ20021785A3 (cs) 2002-09-11
CN1210017C (zh) 2005-07-13
EP1292281B1 (fr) 2004-09-08
ME00245B (me) 2011-02-10
AU757008B2 (en) 2003-01-30
ES2227268T3 (es) 2005-04-01
HU226982B1 (en) 2010-04-28
AU8993501A (en) 2002-04-22
CR6937A (es) 2003-11-28
RS50197B (sr) 2009-05-06
AR031819A1 (es) 2003-10-08
IS6771A (is) 2003-04-08

Similar Documents

Publication Publication Date Title
BE2016C059I2 (fr)
BE2013C048I2 (fr)
BE2011C041I2 (fr)
BE2010C018I2 (fr)
BE2010C009I2 (fr)
JP2003516072A5 (fr)
JP2003518817A5 (fr)
JP2001228781A5 (fr)
JP2002535763A5 (fr)
JP2001224865A5 (fr)
JP2003503251A5 (fr)
JP2000253211A5 (fr)
JP2001094489A5 (fr)
DE60141394D1 (fr)
JP2004500634A5 (fr)
JP2001353215A5 (fr)
JP2001250563A5 (fr)
JP2001070649A5 (fr)
JP2002167092A5 (fr)
CH694022C1 (fr)
JP2002022648A5 (fr)
JP2001217737A5 (fr)
JP2001159879A5 (fr)
BRPI0003419A (fr)
CN300955183S (zh) 连接件